Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotoxicity”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableLooking for participantsNCT06627595
What this trial is testing

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

Who this might be right for
MelanomaImmunotoxicity
University Hospital, Montpellier 160
Testing effectiveness (Phase 2)Looking for participantsNCT05905328
What this trial is testing

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

Who this might be right for
Cytokine Release Syndrome
CytoAgents, Inc. 54
Not applicableLooking for participantsNCT04119713
What this trial is testing

Autoimmunity After Checkpoint Blockade

Who this might be right for
AutoimmunityCancerImmunotoxicity+1 more
Abramson Cancer Center at Penn Medicine 600
Post-approval studies (Phase 4)Study completedNCT05161845
What this trial is testing

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Who this might be right for
ImmunotoxicityVaccine
Shanghai Institute Of Biological Products 1,068
Not applicableStudy completedNCT02794896
What this trial is testing

Anesthetic Depth Effects Upon Immune Competent Cells

Who this might be right for
ImmunotoxicityAnesthesiaInert Gas Narcosis
Heidelberg University 16
Not applicableUnknownNCT04929834
What this trial is testing

Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities

Who this might be right for
Skin ToxicityImmunotoxicity
Jessa Hospital 100
Not applicableUnknownNCT05492643
What this trial is testing

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

Who this might be right for
SARS-CoV-2SafetyImmunotoxicity
Zhongnan Hospital 1,000